View all news

CHMP Issues a Positive Opinion on Janssen's ZYTIGA® to Include Earlier Stage Prostate Cancer Patients

10/13/2017

Multimedia Files:

View all news
Questions? Please contact us:
1-800-950-5089 investor-relations@its.jnj.com